Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Go back to Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
(NASDAQ: CBIO) Delayed: 16.25 -0.64 (3.79%)
Previous Close $16.89    52 Week High $4.57 
Open $16.93    52 Week Low $0.62 
Day High $17.04    P/E N/A 
Day Low $15.76    EPS $0.00 
Volume 375,775